Urinary triaosylceramide (Gb3) as a marker of cardiac disease

• 收藏
• 分享

专利权人:

发明人:

Raphael Schiffmann,Fanny Mochel,Lawrence Sweetman,Sabrina Forni

申请号：

US14729630

公开号：

US09750732B2

申请日:

2015.06.03

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention describes a method for determination of urinary globotriaosylceramide (Gb3) levels in non-Fabry disease cardiac patients. Determination of Gb3 levels provides a screening method for determining cardiac risk and may offer an alternative therapeutic option for cardiac disease management or cardiac disease risk mitigation by lowering Gb3 levels by the use of pharmacological chaperones or other agents.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/